BEIJING: One day after meeting and having talks with visiting Kyrgyz President Sadyr Japarov and Pakistani President Asif Ali ...
Multilateral agreements on visa facilitation among member states of the Shanghai Cooperation Organisation (SCO) would help unlock the countries’ full tourism potential, Secretary-General of the ...
Shanghai Cooperation Organization (SCO) Secretary-General Nurlan Yermekbayev on Thursday ruled out immediate plans for a common payment system within the bloc but stressed efforts to boost national ...
Shanghai's technology insurance premiums reached 5.06 billion yuan ($690 million) in 2024, providing risk coverage of over 25 trillion yuan, according to a report released by the Shanghai Municipal ...
France said Thursday it has sent the first of the promised Mirage jet fighters to Ukraine. French President Emmanuel Macron ...
German optics giant Zeiss announced on Thursday that it will purchase land in the China (Shanghai) Pilot Free Trade Zone to ...
Feverish buying has pumped up shares of Chinese chipmakers, software designers and data centre operators amid patriotic calls for an upward repricing of Chinese assets ...
Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius Biotech, Inc to develop and commercialise an under-development cancer drug. Dr Reddy’s ...
This strategic collaboration marks a significant step towards strengthening Research and Development (R&D) capabilities ...
Dr Reddy’s inks pact with Henlius to commercialize HLX1, a biosimilar candidate in US & Europe: Our Bureau, Bengaluru Thursday, February 6, 2025, 17:20 Hrs [IST] Dr Reddy’s La ...
Dr Reddy's Laboratories has partnered with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar to the cancer drug Darzalex. Henlius will manage development and manufacturing, ...
Dr Reddy’s Laboratories has signed a license deal with Shanghai Henlius Biotech to develop and market HLX15, an investigational cancer drug. Henlius will handle development and manufacturing, ...